Measurement of serum and synovial fluid keratan sulphate and antibody to collagen type II in equine osteoarthritis.

This study compares the concentration of keratan sulphate and the presence of antibodies against collagen type II in the blood and joint fluid of healthy horses and those with osteoarthritis. The researchers found a higher concentration of keratan sulphate in the blood of horses suffering from osteoarthritis, suggesting that this could potentially be used as a marker to detect the condition.

Study Purpose and Design

• The study aimed to investigate the levels of keratan sulphate (KS) and antibodies against collagen type II in the serum (blood) and the synovial fluid (joint fluid) of horses, particularly comparing those with osteoarthritis (OA) to healthy ones.
• The researchers measured these two substances as both are considered crucial in the compositional aspects of the joint, and alterations could point towards a pathological state like OA.

Methods and Measurements

• Two samples were collected from each horse, one sample of serum and one of synovial fluid.
• Tests were then performed on these samples to measure the levels of KS and the presence of anticollagen type II antibodies.

Results

• In horses suffering from OA, a significant increase in serum keratan sulphate levels was found compared to healthy horses, indicating that KS levels could be a potential biomarker for OA.
• However, no significant difference was found in the levels of KS in the synovial fluid between healthy horses and those with OA. This suggests that the systemic changes in KS are more telling than localized changes within the joint itself.
• The study further found no significant increase in the level of anticollagen type II antibodies within the serum and synovial fluid of horses with OA, suggesting that these antibodies might not be relevant in the pathological development of osteoarthritis.

Conclusion and Implications

• The research suggests that the levels of keratan sulphate in the serum could be valuable in detecting OA in horses, potentially providing a tool for veterinarians to identify the early onset of the condition.
• However, no correlation was found between the levels of anticollagen type II antibodies and osteoarthritis, indicating that this aspect does not contribute to the disease process. This does not support the theory of autoimmunity towards collagen leading to OA.